Claiborne Cary J - Insider Non-Derivative Transactions at ADIAL PHARMACEUTICALS, INC. (ADIL) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 23, 2023, Claiborne Cary J's relationship to ADIAL PHARMACEUTICALS, INC. (ADIL) is Director,Officer (Chief Executive Officer), and currently has 1,520,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ADIL insiders.
Data Source: SEC.
Claiborne Cary J - Insider Non-Derivative Transactions at ADIL
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| May 24, 2023 | Acquisition -- (Common Stock) | 420000 | 0 | 1520000 |